Thomas Zander

26.2k total citations
230 papers, 7.0k citations indexed

About

Thomas Zander is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Thomas Zander has authored 230 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Surgery, 86 papers in Pulmonary and Respiratory Medicine and 85 papers in Pathology and Forensic Medicine. Recurrent topics in Thomas Zander's work include Spine and Intervertebral Disc Pathology (65 papers), Esophageal Cancer Research and Treatment (46 papers) and Gastric Cancer Management and Outcomes (42 papers). Thomas Zander is often cited by papers focused on Spine and Intervertebral Disc Pathology (65 papers), Esophageal Cancer Research and Treatment (46 papers) and Gastric Cancer Management and Outcomes (42 papers). Thomas Zander collaborates with scholars based in Germany, United States and Netherlands. Thomas Zander's co-authors include A. Rohlmann, G. Bergmann, Hendrik Schmidt, James C.A. Bardwell, Hans‐Joachim Wilke, Marcel Dreischarf, Alexander Quaas, Milind Rao, Joachim L. Schultze and Christiane J. Bruns and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Thomas Zander

218 papers receiving 6.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Zander Germany	47	3.2k	2.8k	1.7k	1.5k	1.3k	230	7.0k
Raquel M. Gonçalves Portugal	35	1.2k 0.4×	845 0.3×	842 0.5×	1.2k 0.8×	609 0.5×	95	4.4k
Michael T. Bayliss United Kingdom	52	775 0.2×	1.6k 0.6×	1.1k 0.7×	1.7k 1.2×	411 0.3×	113	8.0k
Rex C. Haydon United States	40	522 0.2×	971 0.3×	248 0.1×	4.4k 2.9×	1.3k 1.0×	83	7.5k
Hue H. Luu United States	39	411 0.1×	1.0k 0.4×	164 0.1×	4.1k 2.8×	1.3k 1.0×	83	7.6k
Yasuyuki Fujita Japan	33	427 0.1×	831 0.3×	280 0.2×	1.2k 0.8×	543 0.4×	178	4.5k
Albert Yee Canada	32	583 0.2×	1.1k 0.4×	133 0.1×	1.8k 1.2×	575 0.4×	93	4.1k
Vladimir V. Kalinichenko United States	56	581 0.2×	2.0k 0.7×	98 0.1×	6.1k 4.1×	1.2k 0.9×	125	8.7k
Raimund W. Kinne Germany	38	270 0.1×	758 0.3×	430 0.3×	1.8k 1.2×	992 0.8×	129	6.1k
Eva‐B. Bröcker Germany	36	993 0.3×	210 0.1×	365 0.2×	1.3k 0.9×	1.2k 0.9×	92	4.9k
Nathalia A. Giese Germany	54	327 0.1×	1.3k 0.5×	292 0.2×	3.6k 2.4×	4.0k 3.0×	155	9.0k

Countries citing papers authored by Thomas Zander

Since Specialization

Citations

This map shows the geographic impact of Thomas Zander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Zander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Zander more than expected).

Fields of papers citing papers by Thomas Zander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Zander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Zander. The network helps show where Thomas Zander may publish in the future.

Co-authorship network of co-authors of Thomas Zander

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Zander. A scholar is included among the top collaborators of Thomas Zander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Zander. Thomas Zander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heydt, Carina, Udo Siebolts, Thomas Zander, et al.. (2024). Concurrent KRAS p.G12C mutation and ANK3::RET fusion in a patient with metastatic colorectal cancer: a case report. Diagnostic Pathology. 19(1). 55–55.

Al‐Batran, Salah‐Eddin, Sylvie Lorenzen, Jorge Riera, et al.. (2024). Effect of chemotherapy/targeted therapy alone vs. chemotherapy/targeted therapy followed by radical surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction: The IKF-575/RENAISSANCE phase III trial.. Journal of Clinical Oncology. 42(17_suppl). LBA4001–LBA4001. 13 indexed citations

Wegen, Simone, Johannes Rosenbrock, Maike Trommer, et al.. (2024). Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer. Radiation Oncology. 19(1). 44–44. 7 indexed citations

Brunner, Stefanie, Erkan Çelik, Alexander Damanakis, et al.. (2024). Correlation of primary tumor volume and histopathologic response following neoadjuvant treatment of esophageal adenocarcinoma. European Journal of Surgical Oncology. 50(4). 108003–108003. 2 indexed citations

Gebauer, Florian, Patrick Sven Plum, Alexander Damanakis, et al.. (2023). Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction. Annals of Surgical Oncology. 30(12). 7422–7433. 7 indexed citations

Damanakis, Alexander, Florian Gebauer, Hans Schlößer, et al.. (2023). Combined regression score predicts outcome after neoadjuvant treatment of oesophageal cancer. British Journal of Cancer. 128(11). 2025–2035. 4 indexed citations

Laible, Mark, Stefan Wöll, Özlem Türeci, et al.. (2023). The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis. Journal of Translational Medicine. 21(1). 552–552. 17 indexed citations

Fassunke, Jana, Michael Püsken, Elke Binot, et al.. (2023). Durable Response With Sequential Tyrosine Kinase Inhibitor Treatment in a Patient With ROS1 Fusion–Positive Pancreatic Adenocarcinoma: A Case Report. JCO Precision Oncology. 7(7). e2200467–e2200467. 2 indexed citations

Lordick, Florian, Salah‐Eddin Al‐Batran, Dirk Arnold, et al.. (2023). German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer. Gastric Cancer. 27(1). 6–18. 3 indexed citations

10.

Harbeck, Nadia, Andreas Schneeweiß, Peter Thuss‐Patience, et al.. (2021). Neoadjuvant and adjuvant end-points in health technology assessment in oncology. European Journal of Cancer. 147. 40–50. 9 indexed citations

11.

Plum, Patrick Sven, Florian Gebauer, Maxwell Kramer, et al.. (2019). HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma. BMC Cancer. 19(1). 38–38. 57 indexed citations

12.

Quaas, Alexander, Carina Heydt, Dirk Waldschmidt, et al.. (2019). Alterations in ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma. BMC Gastroenterology. 19(1). 21–21. 7 indexed citations

13.

Zander, Thomas, et al.. (2017). Influence of spinal disc translational stiffness on the lumbar spinal loads, ligament forces and trunk muscle forces during upper body inclination. Medical Engineering & Physics. 46(1). 54–62. 15 indexed citations

14.

Puccio, Francesca Di, et al.. (2016). Influence of Arm Motion on Spatio-temporal Gait Parameters and on Force Data. CINECA IRIS Institutial research information system (University of Pisa). 3(6). 12–16. 5 indexed citations

15.

Zander, Thomas, Andrea Hofmann, Andrea Staratschek‐Jox, et al.. (2011). Blood-Based Gene Expression Signatures in Non–Small Cell Lung Cancer. Clinical Cancer Research. 17(10). 3360–3367. 51 indexed citations

16.

Kahraman, Deniz, Matthias Scheffler, Thomas Zander, et al.. (2011). Quantitative Analysis of Response to Treatment with Erlotinib in Advanced Non–Small Cell Lung Cancer Using ¹⁸F-FDG and 3′-Deoxy-3′-¹⁸F-Fluorothymidine PET. Journal of Nuclear Medicine. 52(12). 1871–1877. 60 indexed citations

17.

Beyer, Marc, Julia Karbach, Michael R. Mallmann, et al.. (2009). Cancer Vaccine Enhanced, Non–Tumor-Reactive CD8+ T Cells Exhibit a Distinct Molecular Program Associated with “Division Arrest Anergy”. Cancer Research. 69(10). 4346–4354. 12 indexed citations

18.

Nogová, Lucia, Ronald Boellaard, Carsten Kobe, et al.. (2009). Downregulation of ¹⁸F-FDG Uptake in PET as an Early Pharmacodynamic Effect in Treatment of Non–Small Cell Lung Cancer with the mTOR Inhibitor Everolimus. Journal of Nuclear Medicine. 50(11). 1815–1819. 24 indexed citations

19.

Chemnitz, Jens M., Julia Driesen, Sabine Claßen, et al.. (2006). Prostaglandin E2 Impairs CD4+ T Cell Activation by Inhibition of lck: Implications in Hodgkin's Lymphoma. Cancer Research. 66(2). 1114–1122. 84 indexed citations

20.

Kadokura, Hiroshi, et al.. (2004). Snapshots of DsbA in Action: Detection of Proteins in the Process of Oxidative Folding. Science. 303(5657). 534–537. 197 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact